UCB has announced positive new three-year data for its inflammatory disease drug Bimzelx (bimekizumab) in adults with active ...

Today, by contrast, the marketers I study complain of being swamped by data and confused by information overload. And when I ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic ...

NewAmsterdam Pharma has shared promising Alzheimer’s disease (AD) biomarker data from a late-stage study of its ...